Dalazatide, a first-in-class blocker of the Kv1.3 potassium channel on effector memory T cells: safety, tolerability and proof of concept immunomodulation in patients with active plaque psoriasis
{"title":"Dalazatide, a first-in-class blocker of the Kv1.3 potassium channel on effector memory T cells: safety, tolerability and proof of concept immunomodulation in patients with active plaque psoriasis","authors":"S. Iadonato","doi":"10.5281/ZENODO.32662","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":315352,"journal":{"name":"Basel Life Science Week","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basel Life Science Week","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/ZENODO.32662","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}